Febuxostat for hyperuricemia in patients with advanced chronic kidney disease (Q42268534)

19 October 2017

Febuxostat for hyperuricemia in patients with advanced chronic kidney disease (English)

1 reference

chronic renal insufficiency

19 October 2017

1 reference

Tetsu Akimoto

1

1 reference

19 October 2017

Yoshiyuki Morishita

2

1 reference

19 October 2017

Chiharu Ito

3

1 reference

19 October 2017

Osamu Iimura

4

1 reference

19 October 2017

Sadao Tsunematsu

5

1 reference

19 October 2017

Yuko Watanabe

6

1 reference

19 October 2017

Eiji Kusano

7

1 reference

19 October 2017

Daisuke Nagata

8

1 reference

19 October 2017

13 August 2014

1 reference

19 October 2017

1 reference

19 October 2017

8

1 reference

19 October 2017

39-43

1 reference

Redox regulation of protein damage in plasma.

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Effect of allopurinol on blood pressure: a systematic review and meta-analysis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Advanced kidney failure and hyperuricemia

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Level of 8-OHdG in drained dialysate appears to be a marker of peritoneal damage in peritoneal dialysis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Epidemiology of gout: an update

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Febuxostat inhibition of endothelial-bound XO: implications for targeting vascular ROS production

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Managing gout: how is it different in patients with chronic kidney disease?

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

The role of urate and xanthine oxidase in vascular oxidative stress: future directions

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

The role of oxidative stress in chronic kidney disease.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Febuxostat compared with allopurinol in patients with hyperuricemia and gout

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Seasonal changes in blood pressure in patients with end-stage renal disease treated with hemodialysis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Renal function in gout: long-term treatment effects of febuxostat

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Comparison of febuxostat and allopurinol for hyperuricemia in cardiac surgery patients (NU-FLASH Trial).

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Japanese guideline for the management of hyperuricemia and gout: second edition.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Frequency of gouty arthritis in patients with end-stage renal disease in Japan.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134003

Efficacy of benzbromarone in hyperuricemic patients associated with chronic kidney disease

17 August 2018

1 reference

12 December 2020

Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout

1 reference

12 December 2020

A repeated oral administration study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with impaired renal function in Japan: pharmacokinetic and pharmacodynamic study

1 reference

12 December 2020

Febuxostat for hyperuricemia: experience with patients on chronic hemodialysis treatment

1 reference

12 December 2020

Gouty arthritis in end-stage renal disease: clinical course and rarity of new cases

1 reference

12 December 2020

Identifiers

DOI

10.4137/DTI.S16524

1 reference

19 October 2017

1 reference

19 October 2017

1 reference